Results 81 to 90 of about 2,987,261 (338)
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells [PDF]
, 2018 Background: It has been proposed that mesenchymal stromal cells (MSCs) promote tumor progression by interacting with tumor cells and other stroma cells in the complex network of the tumor microenvironment. We characterized MSCs isolated and expanded from Apuzzo T., Avanzini M. A., Calcaterra V., Catenacci L., Croce S., D'Angelo P., Di Benedetto V., Maltese A., Mantelli M., Moretta A., Pelizzo G., Scavo E., Stassi G., Todaro M., Veschi V. +14 morecore +1 more sourceGerm Cell Tumors [PDF]
Neuro-Oncology, 2012 Central nervous system (CNS) germ cell tumors (GCTs) are separated into germinomas and nongerminomatous germ cell tumors (NGGCTs). The latter group includes teratoma (mature and immature), teratoma with malignant transformation, yolk sac tumor, embryonal carcinoma, choriocarcinoma, and mixed GCTs.Q.-y. Yang, Z.-p. Chen, T. Hayase, A. Gomi, A. Higaki, Y. Kawahara, T. Kobari, T. Fukuda, Y. Kashii, A. Morimoto, T. Sakatani, M. Y. Momoi, M. Murray, J. Hale, K. Heinemann, F. Saran, G. Calaminus, J. Nicholson, M. Murray, K. Heinemann, J. Hale, F. Saran, J. Nicholson, G. Calaminus, S. Martinez, Y. Khakoo, S. Gilheeney, K. Kramer, S. Wolden, M. Souweidane, I. Dunkel, E. Brichtova, Z. Pavelka, A. Bobekova, O. Magnova, L. Kren, T. Svoboda, A. Sprlakova, P. Slampa, K. Zitterbart, J. Sterba, C. J. Campen, D. Ashby, P. G. Fisher, M. Monje, J. Dagri, J. Torkildson, J. Cheng, R. X. Wang, T. Yock, A. Banerjee, G. Dhall, J. Finlay, T. Yanagisawa, K. Fukuoka, T. Suzuki, T. Kohga, K. Wakiya, J. Adachi, K. Mishima, T. Fujimaki, M. Matsutani, R. Nishikawa, M. Matsutani, G. Calaminus, D. Frappaz, R. D. Kortmann, C. Alapetite, M. L. Garre, U. Ricardi, F. H. Saran, J. Nicholson, G. Calaminus, J. Nicholson, C. Alapetite, R. D. Kortmann, M. L. Garre, U. Ricardi, F. H. Saran, D. Frappaz, T. Czech, J. Nicholson, D. Frappaz, R. D. Kortmann, C. Alapetite, M. L. Garre, U. Ricardi, F. H. Saran, G. Calaminus, R. Walker, J. Hale, T. Koga, T. Suzuki, R. Nishikawa, T. Yanagisawa, K. Fukuoka, M. Matsutani, G. Legault, J. Allen, O. Geludkova, M. Mushinskaya, Y. Kushel, A. Korshunov, A. Melikyan, L. Shishkina, V. Oserova, S. Oserov, N. Maserkina, I. Borodina, E. Kumirova, N. Boyarchuk, S. Gorbatyh, E. Popova, O. Sherbenko, N. Zelinskaya, R. Shammasov, L. Privalova, O. Chulkov, Y. Kosel, A. M. Cappellano, P. Paiva, S. Cavalheiro, P. Dastoli, M. T. Seixas, N. S. Silva, G. C.-F. Chan, M. M.-K. Shing, H.-L. Yuen, R. C.-H. Li, C.-K. Li, S.-Y. Ha, C.-K. Li, H.-H. Chen, F.-C. Chang, Y.-W. Chen, T.-T. Wong, B. Yarascavitch, N. Stein, L. Ribeiro, A. Whitton, J. Duckworth, K. Scheinemann, S. Singh, O. Geludkova, L. Shishkina, S. Ozerov, S. Gorelyshev, N. Maserkina, Y. Trunin, M. Mushinskaya, N. Boyarchuk, I. Borodina, N. Kagawa, Y. Fujimoto, R. Hirayama, Y. Chiba, N. Kijima, H. Arita, M. Kinoshita, N. Hashimoto, M. Maruno, T. Yoshimine, G. P. Guerra, M. Oscanoa, L. Cavero, A. Yabar, E. Ugarte, M. Trivedi, A. Tyagi, J. Goodden, P. Chumas, M. Elliott, S. Picton, N. Robison, S. Prabhu, P. Sun, S. Chi, M. Kieran, P. Manley, L. Cohen, L. Goumnerova, E. Smith, M. Scott, W. London, N. J. Ullrich +184 moreopenaire +2 more sourcesCell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
Molecular Oncology, EarlyView.mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens +17 morewiley +1 more sourceSynthesis of 4-thio-5-(2′′-thienyl)uridine and cytotoxicity activity against colon cancer cells in vitro [PDF]
, 2016 A novel anti-tumor agent 4-thio-5-(2′′-thienyl)uridine (6) was synthesized and the in vitro cytotoxicity activity against mice colon cancer cells (MC-38) and human colon cancer cells (HT-29) was evaluated by MTT assay.Li, Depeng, Ma, Kedong, Qin, Jianzhong, Xu, Yaozhong, Zhang, Xiaohui +4 morecore +1 more sourceTumor stem cells
Pathology & Oncology Research, 2004 Stem cells possess two basic characteristics: they are able to renew themselves and to develop into different cell types. The link between normal stem cells and tumor cells could be examined in three aspects: what are the differences and similarities in the control of self-renewal capacity between stem cells and tumor cells; whether tumor cells arise ...Melinda Hajdú, László Kopperopenaire +3 more sourcesMET variants with activating N‐lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation
Molecular Oncology, EarlyView.MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for Célia Guérin, Audrey Vinchent, Marie Fernandes, Isabelle Damour, Agathe Laratte, Rémi Tellier, Gabriella O. Estevam, Jean‐Pascal Meneboo, Céline Villenet, Clotilde Descarpentries, James S. Fraser, Martin Figeac, Alexis B. Cortot, Etienne Rouleau, David Tulasne +14 morewiley +1 more sourceHepatocyte growth factor, a key tumor-promoting factor in the tumor microenvironment [PDF]
, 2017 The tumor microenvironment plays a key role in tumor development and progression. Stromal cells secrete growth factors, cytokines and extracellular matrix proteins which promote growth, survival and metastatic spread of cancer cells.Galemmo, Robert, Janetka, James, Klampfer, Lidija, Owusu, Benjamin Yaw +3 morecore +2 more sourcesLiquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma
Analytical Cellular Pathology, 2018 Hemangiopericytoma (HPT) is a rare mesenchymal tumor of fibroblastic type and for its rarity is poorly studied. The most common sites of metastatic disease in patients with intracranial HPT are the bone, liver, and lung, suggestive for an hematogenous ...Chiara Nicolazzo, Luciano Colangelo, Alessandro Corsi, Guido Carpino, Angela Gradilone, Chiara Sonato, Cristina Raimondi, Eugenio Gaudio, Paola Gazzaniga, Walter Gianni +9 moredoaj +1 more sourceResponse to neoadjuvant chemotherapy in early breast cancers is associated with epithelial–mesenchymal transition and tumor‐infiltrating lymphocytes
Molecular Oncology, EarlyView.Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.Françoise Derouane, Jérôme Ambroise, Cédric van Marcke, Mieke Van Bockstal, Martine Berlière, Christine Galant, Hélène Dano, Médina Lougué, Elena Benidovskaya, Guy Jerusalem, Vincent Bours, Claire Josse, Jérôme Thiry, Aurélie Daumerie, Caroline Bouzin, Cyril Corbet, François P. Duhoux +16 morewiley +1 more source